Neurocrine Biosciences Defines Clinically Relevant Improvement Threshold in Tardive Dyskinesia Analysis
Neurocrine Biosciences reported an analysis defining a threshold for clinically relevant health improvement in tardive dyskinesia.
Neurocrine Biosciences reported an analysis defining a threshold for clinically relevant health improvement in tardive dyskinesia.